You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
智飛生物(300122.SZ):預計一季度淨利5.02億元-5.52億元 同比增長0%-10%
格隆匯 04-09 16:57

格隆匯4月9日丨智飛生物(300122.SZ)披露2020年第一季度業績預告,公司預計2020年1-3月實現歸屬於上市公司股東的淨利潤5.02億元-5.52億元,同比增長0%-10%。

報告期內,新型冠狀病毒感染肺炎疫情爆發,各地採取了嚴格的防護政策遏制疫情蔓延,物流運輸效率、人員流動情況、預防接種門診工作開展等較去年同期相比發生了較大變化,對產品的推廣、銷售等產生了消極影響。

在此情形下,公司積極承擔社會責任,穩步推動復工復產,在馳援防控前線的同時,全力保障產品的研發、生產、推廣、配送、銷售及進口產品代理等工作。2020年第一季度公司主營業務增長有所放緩,主營業務收入、淨利潤等重要財務指標較上年同期小幅增長。

另外,報告期非經常性損益預計對淨利潤的影響金額約為-1232.03萬元,非經常性損益對公司業績變化不會構成重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account